HARVARD BIOSCIENCE INC — Director's Dealing 2012

Dec 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2012-12-11

Reporting Person: GRAZIANO CHANE (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-11	Common Stock	M	200000	$3.48	Acquired	2645920	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-11	Stock Option (right to buy)	$3.48	M	200000	Disposed	2013-04-08	Common Stock, par value $0.01 per share (200000)	Direct

Footnotes

F1: Includes (a) a deferred stock award of 66,800 restricted stock units which vest in equal installments on Jan 1, 2013 and Jan 1, 2014; (b) a deferred stock award of 40,312 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 105,042 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014, Jan 1, 2015 and Jan 1, 2016; and (d) 2,433,766 shares of common stock held by Mr. Graziano.

F2: Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan.